Characterization of TGFBI in disease has primarily focused on corneal dystrophy where human mutations in the gene encoding this protein cause aberrant folding leading to TGFBI aggregation in the cornea resulting in blindness [15–17]. This evidence concerns the gene TGFBI and corneal dystrophy.